Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaThomas Powles, Petros Grivas, Yohann Loriot et al.|New England Journal of Medicine|2020Cited by 1.5k
American Cancer Society prostate cancer survivorship care guidelinesTed A. Skolarus, Rebecca Cowens-Alvarado, Andrew M. D. Wolf et al.|CA A Cancer Journal for Clinicians|2014Cited by 402
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-UpThomas Powles, Petros Grivas, Se Hoon Park et al.|Journal of Clinical Oncology|2023Cited by 210
The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell CancerAmanda Nizam, Jeanny B. Aragon‐Ching, Logan Rhea et al.|Kidney Cancer|2019Cited by 1
Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancerJeanny B. Aragon‐Ching, Brinda Gupta, LoganP Rhea|Asian Journal of Andrology|2019Cited by 1